Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company.
Hyloris Pharmaceuticals has raised $1.1M in total funding. The most recent round was Grant. The last funding was announced in June 2023.
Hyloris Pharmaceuticals's investors include Meusinvest (Noshaq), Saffelberg Investments, Walloon, Scorpiaux.
Hyloris Pharmaceuticals is headquartered in Liège, Belgium.
Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company.
Hyloris Pharmaceuticals is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hyloris Pharmaceuticals — Funding & Investors." VCBacked, June 8, 2023, https://www.vcbacked.co/company/hyloris-pharmaceuticals. Accessed October 6, 2026.
VCBacked. (2023). Hyloris Pharmaceuticals — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/hyloris-pharmaceuticals
{{cite web |title=Hyloris Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/hyloris-pharmaceuticals |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated